Quebec regulator says claims against Valeant are 'worrying'
TORONTO Oct 22 (Reuters) - The securities regulator in the province of Quebec, where Valeant Pharmaceuticals International is headquartered, said on Thursday that claims against the drugmaker are "worrying" and that it is closely following the situation.
On Wednesday, Citron Research, an influential short-selling firm, in a report accused Valeant of using specialty pharmacies to inflate its revenue, the claims sent Valeant shares into a tailspin and reduced its market capitalization by about $9.6 billion on Wednesday. (Reporting by Euan Rocha; Editing by Jeffrey Benkoe)
© Thomson Reuters 2017 All rights reserved.